MEDIC is a biotechnology company based in the San Francisco Bay Area that is developing a cancer drug target discovery platform. This innovative platform combines CRISPR functional genomics with patient tumor-like cancer models to identify potential targets for cancer drug development. By utilizing cutting-edge techniques and state-of-the-art technologies, MEDIC aims to accelerate the discovery of new cancer treatments that can help improve patient outcomes.